The purpose of this meeting is to develop recommendations to facilitate and promote the adoption of LST designs for regulatory submissions or other purposes.
Meeting Objectives
Discuss findings from a survey of practices
Discuss strategies that companies are using to implement LSTs
3.2 Reflections on Challenges and Potential Solutions by Robert Temple
*The views and opinions expressed in this presentation are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.